三月 2026
- Home
- electroCore
三月 2026的electroCore市场份额分析
At electroCore, we are developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology and metabolic disorders.
electroCore(包含公司地区分支机构)
查看更多网站流量和参与度信息- electrocore.com
electroCore收入截至 三月 2026为 25M - 50M
electroCore主要域名产生的收入
3 年中electroCore主要域名的收入
electroCore主要域名的收入
electroCore热门域名的总访问量
了解electroCore市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
electroCore热门域名的平均访问时长
分析electroCore参与度指标。
过去 3 个月的平均访问时长
子公司明细
electroCore热门域名的平均页面浏览量
了解electroCore如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
electroCore 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻electroCore, Inc. will attend event 25th annual Needham Virtual Healthcare Conference on Apr 15th '26.ROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 15, 2026.
四月 8, 2026阅读更多
新闻electroCore, Inc. will hire Michael Fox as Chief Operating Officer on Apr 1st '26.electroCore, Inc. announced that Joshua Lev will assume the role of interim President and Michael Fox will be joining the Company as Chief Operating Officer in April 2026.
三月 19, 2026阅读更多
新闻electroCore, Inc. attended event 2025 Sleep Awards on Sep 22nd '25.ROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga(TM) Plus handheld vagus nerve stimulation (nVNS) device has been named the "Best Relaxation Gadget" in Esquire's 2025 Sleep Awards.
九月 22, 2025阅读更多
查看 electroCore 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。